Stubbs Jason R, Liu Shiguang, Tang Wen, Zhou Jianping, Wang Yong, Yao Xiaomei, Quarles L Darryl
The Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
J Am Soc Nephrol. 2007 Jul;18(7):2116-24. doi: 10.1681/ASN.2006121385. Epub 2007 Jun 6.
Fibroblastic growth factor 23 (FGF23) regulates renal phosphate reabsorption and 1alpha-hydroxylase activity. Ablation of FGF23 results in elevated serum phosphate, calcium, and 1,25-dihydroxyvitamin D3 [1,25(OH)(2)D] levels; vascular calcifications; and early death. For determination of the independent roles of hyperphosphatemia and excess vitamin D activity on the observed phenotypic abnormalities, FGF23 null mice were fed a phosphate- or vitamin D-deficient diet. The phosphate-deficient diet corrected the hyperphosphatemia, prevented vascular calcifications, and rescued the lethal phenotype in FGF23 null mice, despite persistent elevations of serum 1,25(OH)(2)D and calcium levels. This suggests that hyperphosphatemia, rather than excessive vitamin D activity, is the major stimulus for vascular calcifications and contributes to the increased mortality in the FGF23-null mouse model. In contrast, the vitamin D-deficient diet failed to correct either the hyperphosphatemia or the vascular calcifications in FGF23 null mice, indicating that FGF23 independently regulates renal phosphate excretion and that elevations in 1,25(OH)(2)D and calcium are not sufficient to induce vascular calcifications in the absence of hyperphosphatemia. The vitamin D-deficient diet also improved survival in FGF23 null mice in association with normalization of 1,25(OH)(2)D and calcium levels and despite persistent hyperphosphatemia and vascular calcifications, indicating that excessive vitamin D activity can also have adverse effects in the presence of hyperphosphatemia and absence of FGF23. Understanding the independent and context-dependent interactions between hyperphosphatemia and excessive vitamin D activity, as well as vascular calcifications and mortality in FGF23 null mice, may ultimately provide important insights into the management of clinical disorders of hyperphosphatemia and excess vitamin D activity.
成纤维细胞生长因子23(FGF23)调节肾脏对磷酸盐的重吸收以及1α-羟化酶的活性。敲除FGF23会导致血清磷酸盐、钙和1,25-二羟基维生素D3 [1,25(OH)₂D]水平升高;血管钙化;以及早期死亡。为了确定高磷血症和维生素D活性过高对所观察到的表型异常的独立作用,给FGF23基因敲除小鼠喂食低磷或低维生素D饮食。低磷饮食纠正了高磷血症,预防了血管钙化,并挽救了FGF23基因敲除小鼠的致死表型,尽管血清1,25(OH)₂D和钙水平持续升高。这表明高磷血症而非维生素D活性过高是血管钙化的主要刺激因素,并导致FGF23基因敲除小鼠模型死亡率增加。相比之下,低维生素D饮食未能纠正FGF23基因敲除小鼠的高磷血症或血管钙化,这表明FGF23独立调节肾脏磷酸盐排泄,并且在没有高磷血症的情况下,1,25(OH)₂D和钙水平升高不足以诱导血管钙化。低维生素D饮食还改善了FGF23基因敲除小鼠的存活率,同时使1,25(OH)₂D和钙水平恢复正常,尽管高磷血症和血管钙化持续存在,这表明在存在高磷血症且缺乏FGF23的情况下,维生素D活性过高也可能产生不利影响。了解高磷血症与维生素D活性过高之间的独立和依赖背景的相互作用,以及FGF23基因敲除小鼠中的血管钙化和死亡率,最终可能为高磷血症和维生素D活性过高的临床疾病管理提供重要见解。